C3d‐positive donor‐specific antibodies have a role in pretransplant risk stratification of cross‐match‐positive HLA‐incompatible renal transplantation: United Kingdom multicentre study-Reference-Cited by-同舟云学术

C3d‐positive donor‐specific antibodies have a role in pretransplant risk stratification of cross‐match‐positive HLA‐incompatible renal transplantation: United Kingdom multicentre study

Published:2020-06-25 Issue:9 Volume:33 Page:1128-1139
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Babu Adarsh¹²^ORCID,Khovanova Natasha³,Shaw Olivia⁴,Griffin Sian⁵,Briggs David⁶,Krishnan Nithya S.²,Fletcher Simon²,Imray Christopher¹²,Seitz Adrienne⁷⁸,Baker Richard⁸,Wellberry‐Smith Matthew⁸,Clarke Brendan⁷,Cullen Katherine⁷,Rees Tracey⁹,Edwards Frankie⁹,Burrows Emma⁹,Howe Louise³,Martin Chloe³,Dorling Anthony¹⁰,Zehnder Daniel¹¹¹,Higgins Robert M.¹²,Mitchell Daniel A.¹,Daga Sunil¹⁸

Affiliation:

1. Warwick Medical School University of Warwick Coventry UK

2. Renal Medicine and Transplantation University Hospitals Coventry and Warwickshire NHS Trust Coventry UK

3. School of Engineering University of Warwick Coventry UK

4. Department of Histocompatibility and Immunogenetics Viapath London UK

5. Department of Renal Medicine and Transplantation University of Wales Hospital Cardiff UK

6. NHS Blood and Transplant Birmingham UK

7. Department of Histocompatibility and Immunogenetics Leeds Teaching Hospital NHS Trust Leeds UK

8. Department of Nephrology and Transplantation St James's University HospitalLeeds Teaching Hospital NHS Trust Leeds UK

9. Welsh Transplantation and Immunogenetics Laboratory Cardiff UK

10. Department of Renal Medicine and Transplantation Guys and St Thomas NHS Foundation Trust London UK

11. Department of Nephrology/Acute Medicine North Cumbria University Hospital NHS Trust Carlisle UK

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.13663

Reference60 articles.

1. Significance of the Positive Crossmatch Test in Kidney Transplantation

2. RENAL TRANSPLANTATION AFTER REMOVAL AND PREVENTION OF RESYNTHESIS OF HLA ANTIBODIES

3. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation

4. PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS

5. Antibody-incompatible kidney transplantation in 2015 and beyond

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal;Frontiers in Immunology;2023-10-02

2. The in vitro C3d generating attribute of HLA‐specific antibodies can be used to stratify immune risk in HLA incompatible transplantation by predicting the clinical efficacy of desensitisation;HLA;2023-08-21

3. Complement activation and kidney transplantation; a complex relationship;Immunobiology;2023-07

4. Defining the lower and upper limits of immunological risk of HLA antibody incompatible kidney transplantation: Current state of the art and limitations;Transplant Immunology;2023-02

5. Isolated Pre-existing HLA-DP Donor-Specific Antibodies are Associated With Poorer Outcomes in Renal Transplantation;Kidney International Reports;2022-10